Maastricht UMC+ & GROW attain OECI Comprehensive Cancer Centre status
Maastricht UMC+ Oncology Centre and Maastricht University's research institute GROW – School for Oncology and Developmental Biology have together been accredited as a Comprehensive Cancer Centre by the European Organisation of Cancer Institutes (OECI).
MUMC+ is the first university medical centre and (after Antoni van Leeuwenhoek hospital in Amsterdam) the second hospital in the Netherlands to attain this prestigious certification. The quality mark is valid for five years and means that the centre offers oncological care, scientific research and education at an excellent level.
"This certification is an important milestone in the development of our centre and for the care of patients in our region and far beyond. This is certainly also in recognition for all the work that has been done recently."
The attainment of quality mark was preceded by an intensive accreditation process in which the Oncology Center and GROW worked together.
According to OECI, this cooperation has led to an innovative and dynamic organisation – a frontrunner – that firmly integrates research and knowledge into clinical practice. Underlying this is a strong vision that focusses on survival with function preservation. This means that care and research are continuously aimed at maintaining or restoring all the functions that define a person's health. This includes physical functions, mental wellbeing, social participation and quality of life.
Manon van Engeland, GROW's Scientific Director:
"In terms of research, this means that we focus on improving diagnostics and treatments with fewer side effects. We also focus explicitly on prevention, on preventing cancer. For example, by researching genes, the environment and lifestyle."
According to OECI, in Maastricht, care, research and support are clearly organised around the 'patient journey'. The route that patients take from referral to follow-up at home. In order to realise the best possible care, patient participation is embedded at all levels. From deciding on a treatment together (shared decision) to co-determination on future policy (patient representation in the Oncology Committee).
The certificate was also awarded because of the clear network function. Within OncoZON – Oncological Network Zuid-Oost Nederland – The newly accredited Maastricht Comprehensive Cancer Centre collaborates with eight other regional hospitals and Maastro radiotherapy centre. There is also intensive collaboration with all partners within Maastricht UMC+ who are involved in oncological care and research, such as: CAPHRI – Care and Public Health Research Institute); NUTRIM – School of Nutrition and Translational Research in Metabolism; CTCM – Clinical Trial Center Maastricht and Kankeronderzoekfonds Limburg.